The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro

There is no definite cure for Alzheimer’s disease (AD) due to its multifactorial origin. Drugs that inhibit acetylcholinesterase (AChE), such as rivastigmine, are promising symptomatic treatments for AD. Emerging evidence suggests that insulin therapy can hinder several aspects of AD pathology. Insu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Mahsa Babaei, Mohamed H. Al-Sabri, Helgi B. Schiöth
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/92921d97535b4d4ea6eb9d82c6c12859
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!